Essa Pharma (EPIX) Noseedives 66 % before stopping the work

We have recently published 10 large inspection stocks. Essa Pharma Inc. (NASDAQ: EPIX) is one of the worst Tuesday performance.

Essa Pharma was 66.39 percent on Tuesday, ending at $ 0.2631 each, as investors sold positions after paying 80 million dollars to their shareholders as part of stopping its work.

In a statement, Essa Pharma Inc. said. (NASDAQ: Epix) has returned about $ 1.69 per share for shareholders as of August 22 record. He also corrected the date of the previous distribution until August 22, instead of August 25 as announced previously.

The treatment was in line with the planned integration of Essa Pharma Inc. (NASDAQ: Epix) with Xenotherapics, Inc. And according to which the latter will get all its outcomes and distinguished shares.

Under the terms of the agreement, Essa Pharma Inc. will receive. (NASDAQ: EPIX) A cash payment that will be determined based on its cash balance when closing after deducting the costs of transactions, reserves for opponents, legal expenses, and treatment fees.

In addition, each shareholder will get an uncomfortable emergency value per share, which will take the shareholder to receive a supportive part of $ 2.95 million or $ 0.06 per CVR within 18 months after treatment.

Although we acknowledge the capacity of EPIX as an investment, our conviction lies in the belief that some artificial intelligence shares are more promises to make higher and limited returns than negative risks. If you are looking for a very cheap inventory of artificial intelligence and is also a major beneficiary of the Trump and Bundge tariff, see our free report on The best inventory of artificial intelligence in the short term.